Mount Sinai surgeons first in NY to perform minimally-invasive heart bypass surgery
Current Location:
> This Story

Log in or Register to rate this News Story
Forward Printable StoryPrint Comment




Cardiology Homepage

New 3D bioprinting method can create organs from collagen Major structural protein in the human body

New AI solution identifies high-risk patients from chest X-rays MGH tool may help detect heart disease, lung cancer

Key success criteria for the creation of an outpatient heart failure clinic Deb Thompson, senior consulting manager for Cardiology at Philips discusses what is required for the efficient management of a multi-disciplinary heart care team

Cardiology occupies a unique space in medical informatics Looking at enterprise imaging and informatics through the lens of cardiology at SIIM

MiE showcases cardiac PET scanner, Ancoris, at SNMMI Provides simultaneous 3D cardiac PET perfusion and CFR

AI tool for Alexa and smart devices detects cardiac arrest in sleeping patients Monitors patients for agonal breathing

New dye helps control 'lighting' for sharper images of heart May help identify early signs of heart disease

Evaluating the cost-effectiveness of AEDs in the U.S. Insights from Dr. Lars W. Andersen on research he conducted and what it should mean for the future of public defibrillators

The 2019 Heart Rhythm Society scientific sessions: advanced technology in electrophysiology Four key takeaways

New machine learning algorithm could decide who is best for heart failure treatment Could help prevent sudden death from heart failure

Mount Sinai surgical team
performing TECAB

Mount Sinai surgeons first in NY to perform minimally-invasive heart bypass surgery

by Lauren Dubinsky , Senior Reporter
Mount Sinai Heart recently became the first in New York to offer a minimally-invasive type of heart bypass surgery.

The procedure, which is called totally endoscopic coronary arterial bypass surgery (TECAB), is performed using Intuitive Surgical's da Vinci Surgical System and Cardica's C-Port Flex-A. Surgeons make four one-centimeter-long incisions and maneuver the robotic instruments inside to harvest the mammary artery.

Story Continues Below Advertisement

Servicing GE/Siemens Nuclear Medicine equipment with OEM trained engineers

Numed, a well established company in business since 1975 provides a wide range of service options including time & material service, PM only contracts, full service contracts, labor only contracts & system relocation. Call 800 96 Numed for more info.

A specialized automatic device is then use to connect the mammary artery to the coronary artery on the front wall of the heart and 13 small stainless steel clips are placed to hold the arteries together.

During the conventional heart bypass procedure, surgeons have to open the patient’s chest and sew the arteries together by hand. Since the incision can be up to 12 inches long, patients have to remain in the hospital for seven to 10 days and can’t resume their normal activities for up to three months.

Patients who undergo TECAB are able to leave the hospital one to four days following surgery, and can resume their normal daily activities after one to two weeks. This is especially beneficial for patients who are not ideal candidates for conventional open-chest bypass.

Patients with a limited amount of blockages on the left side of their heart are the best candidates for TECAB. However, those who underwent heart surgery or were exposed to radiation therapy near the chest in the past are not able to receive TECAB.

TECAB offers patients a faster recovery, lower risk of infection and less pain and scarring, but the downside is that it’s very challenging for surgeons to perform. Only a few bypass surgeons around the globe have the skill and training required to perform it.

“The procedure is very technically demanding and requires proficiency in off-pump coronary surgery as well as robotic surgery," Dr. Gianluca Torregrossa, one of the surgeons who performed the procedure at Mount Sinai, told HCB News. "That makes it feasible by highly-skilled teams."

Dr. John Puskas, who performed the procedure alongside Torregrossa, believes that TECAB could eventually become the standard of care for coronary artery disease. But he added that more surgeons would have to learn how to do it for that to happen.

“Technology though is improving, making this operation easier,” said Torregrossa. “We are expecting, in the near future, the introduction in the market of major innovation that could lead to adoption of [this] technique.”

Back to HCB News
  Pages: 1

Cardiology Homepage

You Must Be Logged In To Post A Comment